BHC:NYE-Bausch Health Companies Inc (USD)

COMMON STOCK | Drug Manufacturers - Specialty & Generic |

Last Closing

USD 5.63

Change

0.00 (0.00)%

Market Cap

USD 2.07B

Volume

3.57M

Analyst Target

USD 26.59
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-03 )

Largest Industry Peers for Drug Manufacturers - Specialty & Generic

Symbol Name Price(Change) Market Cap
ZTS Zoetis Inc

N/A

USD 83.17B
TAK Takeda Pharmaceutical Co Ltd A..

N/A

USD 47.69B
HLN Haleon plc

N/A

USD 46.39B
RDY Dr. Reddy’s Laboratories Ltd..

N/A

USD 13.90B
CTLT Catalent Inc

N/A

USD 11.03B
ELAN Elanco Animal Health

N/A

USD 7.59B
AMRX Amneal Pharmaceuticals, Inc. C..

N/A

USD 2.60B
CPHI China Pharma Holdings Inc

N/A

USD 3.04M
YCBD cbdMD Inc

N/A

USD 2.14M
EBS Emergent Biosolutions Inc

N/A

N/A

ETFs Containing BHC

MJJ 9.90 % 0.00 %

N/A

N/A
MJO 9.90 % 0.00 %

N/A

N/A
HHL:CA Harvest Healthcare Leader.. 5.08 % 1.15 %

N/A

N/A
FMK 4.35 % 0.70 %

N/A

N/A
FIW First Trust Water ETF 3.78 % 0.55 %

N/A

N/A
BUZ 3.50 % 0.75 %

N/A

N/A
ZPDI:F SPDR S&P U.S. Industrials.. 2.81 % 0.00 %

N/A

USD 0.24B
ZPDI:XETRA SPDR S&P U.S. Industrials.. 2.81 % 0.00 %

N/A

USD 0.24B
SXLI:LSE SPDR S&P U.S. Industrials.. 2.50 % 0.00 %

N/A

N/A
IISU:LSE iShares S&P 500 Industria.. 2.49 % 0.00 %

N/A

N/A
VIS Vanguard Industrials Inde.. 2.12 % 0.10 %

N/A

N/A
UXI ProShares Ultra Industria.. 1.56 % 0.95 %

N/A

N/A
OEW 1.25 % 0.40 %

N/A

N/A
JNKS:LSE SSgA SPDR ETFs Europe I p.. 0.86 % 0.00 %

N/A

USD 0.17B
SYBK:F SSgA SPDR ETFs Europe I p.. 0.84 % 0.00 %

N/A

USD 0.14B
SYBK:XETRA SPDR Barclays 0-5 Year US.. 0.84 % 0.00 %

N/A

USD 0.13B
SJNK:SW SPDR® Bloomberg SASB U.S.. 0.84 % 0.00 %

N/A

USD 0.17B
SJNK:LSE SSgA SPDR ETFs Europe I p.. 0.74 % 0.00 %

N/A

N/A
BND Vanguard Total Bond Marke.. 0.01 % 0.04 %

N/A

N/A
BSJL 0.00 % 0.41 %

N/A

N/A
CJNK 0.00 % 0.30 %

N/A

N/A
HYG iShares iBoxx $ High Yiel.. 0.00 % 0.49 %

N/A

N/A
ITA 0.00 % 0.42 %

N/A

N/A
IYJ 0.00 % 0.42 %

N/A

N/A
RFUN 0.00 % 0.51 %

N/A

N/A
SHYL Xtrackers Short Duration .. 0.00 % 0.20 %

N/A

USD 0.10B
HIG:CA Global Healthcare Income .. 0.00 % 1.02 %

N/A

CAD 0.05B
HYGV FlexShares® High Yield V.. 0.00 % 0.37 %

N/A

USD 1.46B
PHYL PGIM Active High Yield Bo.. 0.00 % 0.00 %

N/A

USD 0.13B
SJB ProShares Short High Yiel.. 0.00 % 0.95 %

N/A

USD 0.09B
VNLA Janus Henderson Short Dur.. 0.00 % 0.35 %

N/A

USD 2.21B
HYLB Xtrackers USD High Yield .. 0.00 % 0.20 %

N/A

USD 3.58B
BSJP Invesco BulletShares 2025.. 0.00 % 0.42 %

N/A

USD 1.03B
WNDU:LSE SPDR® MSCI World Industr.. 0.00 % 0.00 %

N/A

N/A
XDWI:LSE Xtrackers MSCI World Indu.. 0.00 % 0.00 %

N/A

N/A
DXS3:F Xtrackers - S&P 500 Inver.. 0.00 % 0.00 %

N/A

N/A
SYBJ:F SSgA SPDR ETFs Europe I P.. 0.00 % 0.00 %

N/A

USD 0.49B
NUHY Nuveen ESG High Yield Cor.. 0.00 % 0.00 %

N/A

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Drug Manufacturers - Specialty & Generic) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -29.80% 20% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -29.80% 20% F 6% D-
Trailing 12 Months  
Capital Gain -37.86% 20% F 6% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return -37.86% 20% F 6% D-
Trailing 5 Years  
Capital Gain -75.86% 29% F 4% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -75.86% 29% F 4% F
Average Annual (5 Year Horizon)  
Capital Gain -6.64% 33% F 13% F
Dividend Return -6.64% 33% F 10% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 50.87% 40% F 17% F
Risk Adjusted Return -13.05% 40% F 20% F
Market Capitalization 2.07B 30% F 67% D+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Poor capital utilization

The company management has delivered below median return on invested capital in the most recent 4 quarters compared to its peers.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector